Pirprofen

Pirprofen
Clinical data
ATC code	M01AE08 (WHO) ;
Identifiers
	IUPAC name 2-[3-chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)phenyl]propanoic acid;
CAS Number	31793-07-4 ;
PubChem CID	35935;
ChemSpider	33051 ;
UNII	T7KN291890;
KEGG	D05515 ;
ChEMBL	ChEMBL188952 ;
CompTox Dashboard (EPA)	DTXSID7023489 ;
ECHA InfoCard	100.046.172
Chemical and physical data
Formula	C13H14ClNO2
Molar mass	251.71 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)C(c1cc(Cl)c(cc1)N2C/C=C\C2)C;
	InChI InChI=1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17) ; Key:PIDSZXPFGCURGN-UHFFFAOYSA-N ;
	(verify)

Pirprofen was a nonsteroidal anti-inflammatory drug (NSAID) that was brought to market by Ciba-Geigy in 1982 as a treatment for arthritis and pain. Its label was restricted after adverse events arose, including some cases of fatal liver toxicity. Ciba-Geigy voluntarily withdrew the drug from the market worldwide in 1990.^[1]^:223

References

^ WHO. Consolidated List of Products - Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or Not Approved by Governments, Twelfth Issue - Pharmaceuticals. United Nations - New York, 2005

[1] WHO. Consolidated List of Products - Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or Not Approved by Governments, Twelfth Issue - Pharmaceuticals. United Nations - New York, 2005

[1]

Clinical data

ATC code	M01AE08 (WHO)
Identifiers
IUPAC name 2-[3-chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)phenyl]propanoic acid
CAS Number	31793-07-4
PubChem CID	35935
ChemSpider	33051
UNII	T7KN291890
KEGG	D05515
ChEMBL	ChEMBL188952
CompTox Dashboard (EPA)	DTXSID7023489
ECHA InfoCard	100.046.172
Chemical and physical data
Formula	C₁₃H₁₄ClNO₂
Molar mass	251.71 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(O)C(c1cc(Cl)c(cc1)N2C/C=C\C2)C
InChI InChI=1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17) Key:PIDSZXPFGCURGN-UHFFFAOYSA-N
(verify)